Olutasidenib

Olutasidenib, sold under the brand name Rezlidhia, is an anticancer medication used to treat relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation.Olutasidenib is an isocitrate dehydrogenase-1 (IDH1) inhibitor.It is taken by mouth